- Targeted stakeholdersExpands patient access by allowing a yearlong contraceptive supply in a single fill, reducing pharmacy visits.
- Targeted stakeholdersLikely improves contraceptive adherence and continuity of care, potentially lowering unintended pregnancy rates.
- Targeted stakeholdersReduces out-of-pocket costs for enrollees because covered contraceptive supplies are provided without cost-sharing.
Convenient Contraception Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The Convenient Contraception Act amends the Public Health Service Act to require group and individual health plans to allow enrollees to obtain up to a 365-day supply of contraceptives in a single fill or refill without cost-sharing.
The rule applies to plan years beginning on or after January 1, 2026.
HHS, Labor, and Treasury must begin outreach within 90 days of enactment to inform providers and enrollees about the change.
Technocratic, modest-impact bill that improves access to contraception but occupies a politically sensitive policy area with potential legal and ideological resistance.
Relative to its intended legislative type, this bill is a focused statutory amendment that clearly creates a new coverage entitlement and situates the requirement within the Public Health Service Act with an effective date and a short outreach mandate. It provides a clear single-sentence operational rule (up to 365-day supply, single fill/refill, no cost-sharing) but leaves many implementation, fiscal, enforcement, and edge-case details to implementing agencies or future rulemaking.
Liberal emphasizes access and equity benefits
Who stands to gain, and who may push back.
- Targeted stakeholdersCould increase short-term insurer or plan costs and affect premium calculations or cash flow.
- Targeted stakeholdersMay create pharmacy inventory, dispensing, and storage challenges when issuing yearlong supplies.
- Targeted stakeholdersRaises potential for unused medication waste if patients discontinue or change methods during the year.
Why the argument around this bill splits.
Liberal emphasizes access and equity benefits
Likely strongly supportive because the bill expands contraceptive access, reduces cost barriers, and increases reproductive autonomy.
Supporters will view the single-fill 365-day option as evidence-based convenience that improves adherence and equity.
Generally supportive of expanded access but cautious about costs, administrative implementation, and legal risks.
Wants clear guidance, cost estimates, and monitoring to ensure effective rollout without unintended consequences.
Likely opposed because the bill imposes a federal insurance coverage mandate and could raise costs or conflict with employer and pharmacy conscience protections.
Skeptical of federal expansion into private insurance choices.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, modest-impact bill that improves access to contraception but occupies a politically sensitive policy area with potential legal and ideological resistance.
- Potential litigation or exemptions based on religious objections
- No cost estimate or CBO score included
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes access and equity benefits
Technocratic, modest-impact bill that improves access to contraception but occupies a politically sensitive policy area with potential lega…
Relative to its intended legislative type, this bill is a focused statutory amendment that clearly creates a new coverage entitlement and situates the requirement within the Public Health Service Act with an effective d…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.